Don’t Biopsy Your Prostate: What They Don’t Tell You About Gleason 7, 8 & 9

In this episode of Intellectual Medicine, Dr. Stephen Petteruti challenges the conventional thinking around prostate biopsies, Gleason scores, and treatment decisions for prostate cancer. He explains why a high Gleason score, including Gleason 7, 8, or 9, may indicate a higher risk of progression but does not automatically prove that aggressive treatment will improve survival. Drawing on studies including the PROTECT-T trial, he argues that surgery, radiation, and watchful waiting often show similar long-term prostate cancer mortality outcomes, while invasive treatments can carry serious consequences. Dr. Petteruti also discusses why biopsy results may not always provide the clarity men are promised and why PSA, MRI, and PSMA testing can offer repeatable ways to monitor risk. Beyond the clinical discussion, he emphasizes the importance of vitality, peace of mind, and making informed decisions without being driven by fear. His core message is that men should preserve strength, independence, and quality of life while carefully weighing their options.Timestamps:(00:29) Why vitality matters before disease or decline(01:37) The false trade-off in prostate cancer treatment(02:30) What a Gleason score does and does not mean(04:13) Facing a Gleason 8 or 9 diagnosis without panic(04:36) Comparing treatment outcomes in high Gleason prostate cancer(06:27) What the PROTECT-T trial suggests about surgery, radiation, and monitoring(07:48) The difficult decision between treatment risk and regret(10:03) Why watchful waiting is not the same as taking action(12:29) Gleason scores, progression risk, and treatment outcomes(14:25) Why biopsy may not determine the best treatment path(15:35) PSA, MRI, and repeatable monitoring as alternatives(16:33) Why men with high Gleason scores still have time to think(17:27) Living with vitality while making prostate cancer decisions(18:37) Why prostate cancer care needs a broader health perspective(20:47) The mission behind Intellectual Medicine and the Men’s Vitality GroupEnjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.📚 ResourcesDr. Petteruti Men's Vitality Grouphttps://www.intellectualmedicine.com/membershipFight Cancer Like a Manhttps://www.amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQDr. Petteruti's Newsletterhttps://drstephenpetteruti.substack.com/subscribePodcast Show Noteshttps://www.intellectualmedicine.com/podcast-notes🌐 Learn MoreDr. Stephen Petterutihttps://www.drstephenpetteruti.com/Intellectual Medicinehttps://www.intellectualmedicine.com/📱 Connect with Dr. PetterutiInstagramhttps://www.instagram.com/dr.stephenpetteruti/Facebookhttps://www.facebook.com/dr.stephenpetteruti🎧 Listen to the PodcastApple Podcastshttps://podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409Spotifyhttps://open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1#Overdiagnosis #ProstateHealth #MensVitality #ActiveSurveillanceDisclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.